Altered response to ibutilide in a heart failure model

Cardiovascular Research

Volumn 49, Issue 1, 2001, Pages 94-102

  Chugh, Sumeet S ^a,b   Johnson, Susan B ^a   Packer, Douglas L ^a  

^a MAYO CLINIC   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antiarrhythmic agents; Heart failure; K channel; Remodeling; Ventricular arrhythmias

Indexed keywords

IBUTILIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; DRUG SAFETY; FEMALE; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; MALE; NONHUMAN; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; MALE; SULFONAMIDES; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034747793     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00235-2     Document Type: Article

References (38)

1. Characteristics of action potentials of hypertrophied myocardium from rats with renal hypertension
2. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure
3. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure
4. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy
5. Impact of volume loading and load reduction on ventricular refractoriness and conduction properties in canine congestive heart failure
6. + currents in isolated human ventricular myocytes from patients with terminal heart failure
7. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure
8. Action potential and ionic remodeling in a dog model of heart failure
9. Metabolic inhibition of I(Ca,L) and I(K) differs in feline left ventricular hypertrophy
10. The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: A dangerous imbalance in the risk-benefit ratio
11. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
12. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter
13. Efficacy of ibutilide for termination of atrial fibrillation and flutter
14. Proarrhythmia during drug treatment of supraventricular tachycardia: Paradoxical risk of sinus rhythm for sudden death
15. Clinical predictors of arrhythmia worsening by antiarrhythmic drugs
16. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation
17. Taking the idio out of idiosyncratic - Predicting torsades de pointes
18. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog
19. A simple technique for production of chronic complete heart block in dogs
20. In vitro validation of a new cardiac catheter technique for recording monophasic action potentials
21. Relation of monophasic action potential recorded with contact electrode to underlying transmembrane action potential properties in isolated cardiac tissues: A systematic microelectrode validation study
22. Electrophysiologic substrate associated with pacing-induced heart failure in dogs: Potential value of programmed stimulation in predicting sudden death
23. + current (I(Kr)) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects
24. + current in guinea pig ventricular cells
25. Proarrhythmic effects of ibutilide in a canine model of pacing induced cardiomyopathy
26. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions
27. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia
28. Electropharmacologic characteristics of ventricular proarrhythmia induced by ibutilide
29. Triggered ventricular rhythms in 1-day-old myocardial infarction in the dog
30. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes
31. Class III. Antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence
32. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and D-sotalol using the dog as its own control
33. Ventricular activation patterns of spontaneous and induced ventricular rhythms in canine one-day-old myocardial infarction, Evidence for focal and reentrant mechanisms
34. Bradycardia-dependent triggered activity: Relevance to drug-induced multiform ventricular tachycardia
35. Sudden cardiac death in heart failure. The role of abnormal repolarization
36. + current in the ferret heart
37. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents